1,196
Views
0
CrossRef citations to date
0
Altmetric
Perspective

Evidence-Based Policies in Public Health to Address COVID-19 Vaccine Hesitancy

ORCID Icon & ORCID Icon
Pages 261-273 | Received 03 Feb 2022, Accepted 01 Mar 2023, Published online: 04 Apr 2023

References

  • MacDonald NE , SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine33(34), 4161–4164 (2015).
  • Chirico F , Teixeirada Silva JA , TsigarisP , SharunK. Safety and effectiveness of COVID-19 vaccines: a narrative review. Indian J. Med. Res.155(1), 91–104 (2022).
  • Veldhoen M , SimasJP. Endemic SARS-CoV-2 will maintain post-pandemic immunity. Nat. Rev. Immunol.21(3), 131–132 (2021).
  • Achrekar GC , BatraK , UrankarYet al. Assessing COVID-19 booster hesitancy and its correlates: an early evidence from India. Vaccines10(7), 1048 (2022).
  • Szarpak L , PrucM , NavolokinaAet al. Omicron variants of the SARS-CoV-2: a potentially significant threat in a new wave of infection. Disaster. Emeg. Med. J.7(3), (2022).
  • Magen O , WaxmanJG , Makov-AssifMet al. Fourth dose of BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N. Engl. J. Med.386(17), 1603–1614 (2022).
  • Stasi C , MeoniB , VollerF , SilvestriC. SARS-CoV-2 vaccination and the bridge between first and fourth dose: where are we?Vaccines10(3), 444 (2022).
  • Vergara RJD , SarmientoPJD , LagmanJDN. Building public trust: a response to COVID-19 vaccine hesitancy predicament. J. Public Health43(2), e291–e292 (2021).
  • Lockyer B , IslamS , RahmanAet al. Understanding COVID-19 misinformation and vaccine hesitancy in context: findings from a qualitative study involving citizens in Bradford, UK. Health Expect.24(4), 1158–1167 (2021).
  • Vulpe S . Understanding vaccine hesitancy as extended attitudes. Eur. Fev. Appl. Sociol.13(20), 43–57 (2020).
  • Shaw C , VanadiaS. Utilitarianism on the front lines: COVID-19, public ethics, and the “hidden assumption” problem. Ethics Bioethics12(1-2), 60–78 (2022).
  • Chirico F , Teixeirada Silva JA , SharunKet al. Global COVID-19 vaccine inequality: an overview of critical factor and possible solutions. J. Health Soc. Sci.7(3), 267–282 (2022).
  • Germani F , Biller-AndornoN. The anti-vaccination infodemic on social media: a behavioral analysis. PLOS ONE16(3), e0247642 (2021).
  • Ullah I , KhanKS , TahirMJ , AhmedA , HarapanH. Myths and conspiracy theories on vaccines and COVID-19: potential effect on global vaccine refusals. Vacunas22(2), 93–97 (2021).
  • Gabarda A , ButterworthSW. Using best practices to address COVID-19 vaccine hesitancy: the case for the motivational interviewing approach. Health Promot. Pract.22(5), 611–615 (2022).
  • SAGE (Strategic Advisory Group of Experts) Working Group on Vaccine Hesitancy . Report of the SAGE Working Group on Vaccine Hesitancy. ( cited February 11, 2023). www.asset-scienceinsociety.eu/sites/default/files/sage_working_group_revised_report_vaccine_hesitancy.pdf (2014).
  • Chirico F , Teixeirada Silva JA. Effective and ethical communication of COVID-19 health policies and strategies require transparent open data sharing between scientists, governments and policy makers. Oman Med. J.37(5), e418 (2022).
  • Patone M , MeiXW , HandunnetthiLet al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat. Med.28(2), 410–422 (2022).
  • van Dijk F , Caraballo-AriasY. Where to find evidence-based information on occupational safety and health?Ann. Global Health87(1), 6 (2021).
  • Guidry JPD , LaestadiusLI , VragaEKet al. Willingness to get the COVID-19 vaccine with and without emergency use authorization. Amer. J. Infect. Control49(2), 137–142 (2021).
  • Awadasseid A , WuYL , TanakaY , ZhangW. Current advances in the development of SARS-CoV-2 vaccines. Int. J. Biol. Sci.17, 8–19 (2021).
  • Laine C , CottonD , MoyerDV. COVID-19 vaccine: promoting vaccine acceptance. Ann. Intern. Med.174(2), 252–253 (2021).
  • Polack FP , ThomasSJ , KitchinNet al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. New Engl. J. Med.383(27), 2603–2615 (2020).
  • Banerji A , NortonAE , BlumenthalKG , StoneCAJr , PhillipsE. Rapid progress in our understanding of COVID-19 vaccine allergy: a cause for optimism, not hesitancy. J. Allergy Clin. Immunol.150(1), 12–16 (2022).
  • Payberah E , PayberahD , SarangiA , GudeJ. COVID-19 vaccine hesitancy in patients with mental illness: strategies to overcome barriers – a review. J. Egypt Public Health Assoc.97, 5 (2022).
  • Collier AY , McMahanK , YuJet al. Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women. JAMA325(23), 2370–2380 (2021).
  • La Vecchia C , AlicandroG , NegriEet al. Attitudes towards COVID-19 vaccination and containment measures in Italy and the role of occupational physicians. Med. Lav.113(2), e2022018 (2022).
  • Chirico F , NuceraG , SzarpakLet al. The cooperation between occupational and public health stakeholders and its decisive role in the battle against the COVID-19 pandemic. Disaster Med. Public Health Prep.23, 17, e100 (2021).
  • Mills MC , RüttenauerT. The effect of mandatory COVID-19 certificates on vaccine uptake: synthetic-control modelling of six countries. Lancet Public Health7(1), e15–e22 (2022).
  • Chirico F , NuceraG , SaccoAet al. Protecting hospitals from SARS-CoV-2 infection: a review-based comprehensive strategy for COVID-19 prevention and control. G. Ital. Med. Lav. Ergon.44(1), 32–40 (2022).
  • Montanari Vergallo G , DelRio A , NegroF , ZaamiS. COVID-19 vaccine mandates: what are the current European public perspectives?Eur. Rev. Med. Pharmacol. Sci.26(2), 643–652 (2022).
  • Franco JVA . Should COVID-19 vaccination be mandatory?BMJ Evid. Based Med.26(6), 269–270 (2021).
  • WHO . COVID-19 and mandatory vaccination: ethical considerations and caveats: policy brief, 13 April 2021. World Health organization 2021. Available from: https://apps.who.int/iris/handle/10665/340841 ( cited February 11, 2023).
  • Chirico F , MagnavitaN. Covid-19 infection in Italy: an occupational injury. S. Afr. Med. J.110(6), 12944 (2020).
  • Edwards B , BiddleN , GrayM , SollisK. COVID-19 vaccine hesitancy and resistance: correlates in a nationally representative longitudinal survey of the Australian population. PLOS ONE16(3), e0248892 (2021).
  • Murphy J , VallièresF , BentallRPet al. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat. Commun.12(1), 29 (2021).
  • Gostin LO , SalmonDA , LarsonHJ. Mandating COVID-19 vaccines. JAMA325(6), 532–533 (2021).
  • Eberhardt CS , SiegristCA. Is there a role for childhood vaccination against COVID-19?Pediatr. Allergy Immunol.32(1), 9–16 (2021).
  • Tsabouri S , MakisA , KosmeriC , SiomouE. Risk factors for severity in children with coronavirus disease 2019: a comprehensive literature review. Pediatr. Clin. North Amer.68(1), 321–338 (2021).
  • Luxi N , GiovanazziA , CapuanoAet al. COVID-19 vaccination in pregnancy, paediatrics, immunocompromised patients, and persons with history of allergy or prior SARS-CoV-2 infection: overview of current recommendations and pre- and post-marketing evidence for vaccine efficacy and safety. Drug Saf.44(12), 1247–1269 (2021).
  • Feldstein LR , TenfordeMW , FriedmanKGet al. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA325(11), 1074–1087 (2021).
  • Doherty M , BuchyP , StandaertB , GiaquintoC , Prado-CohrsD. Vaccine impact: benefits for human health. Vaccine34(52), 6707–6714 (2016).
  • Batelaan K . ‘It's not the science we distrust; it's the scientists’: reframing the anti-vaccination movement within Black communities. Glob. Public Health17(6), 1099–1112 (2022).
  • Gibelli F , RicciG , SirignanoA , DeLeo D. COVID-19 Compulsory vaccination: legal and bioethical controversies. Front. Med.9, 821522 (2022).
  • Pennings S , SymonsX. Persuasion, not coercion or incentivization, is the best means of promoting COVID-19 vaccination. J. Med. Ethics47, 709–711 (2021).
  • WHO . Sharing and reuse of health-related data for research purposes: WHO policy and implementation guidance. www.who.int/publications/i/item/9789240044968 ( cited February 11, 2023).
  • ISS (Istituto Superiore di Sanità) . Impact of COVID-19 vaccination on the risk of SARS-CoV-2 infection and hospitalization and death in Italy (27.12.2020 – 14.07.2021). English version of the ISS report. (2021). Available from: Impact of COVID-19 vaccination on the risk of SARS-CoV-2 infection and hospitalization and death in Italy (27.12.2020 – 14.07.2021). English version of the ISS report – ISS (EN) – ISS [cited February 11, 2023].
  • Grasselli G , GrecoM , ZanellaAet al. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern. Med.180(10), 1345–1355 (2020). Erratum: JAMA Intern. Med. 181(7), 1021 (2021).
  • Motos A , López-GavínA , RieraJet al. Higher frequency of comorbidities in fully vaccinated patients admitted to ICU due to severe COVID-19: a prospective, multicenter, observational study. Eur. Respir. J.59(2), 2102275 (2022).
  • NSW Government . COVID-19 Critical Intelligence Unit: hospitalisation and ICU admission relative risk (2021). aci.health.nsw.gov.au/__data/assets/pdf_file/0007/690073/Evidence-Check-Hospitalisation-and-ICU-admission-relative-risk.pdf ( cited February 11, 2023).
  • Mielke N , JohnsonS , BahlA. Boosters reduce in-hospital mortality in patients with COVID-19: an observational cohort analysis. Lancet Reg. Health Am.8, 100227 (2022).
  • Ioannidis JPA . Benefit of COVID-19 vaccination accounting for potential risk compensation. NPJ Vaccines6, 99 (2021).
  • Long S , LoutfiD , KaufmanJS , SchusterT. Limitations of Canadian COVID-19 data reporting to the general public. J. Public Health Policy43(2), 203–221 (2022).
  • Beckmann JS , LewD. Reconciling evidence-based medicine and precision medicine in the era of big data: challenges and opportunities. Genome Med.8(1), 134 (2016).
  • Brownson RC , FieldingJE , MaylahnCM. Evidence-based public health: a fundamental concept for public health practice. Annu. Rev. Public Health30, 175–201 (2009).
  • Watson R , McCraeN. Will evidence-based medicine be another casualty of COVID-19?J. Adv. Nurs.76(12), 3228–3230 (2020).
  • Fauci AS , LaneHC , RedfieldRR. Covid-19 – Navigating the uncharted. New Engl. J. Med.382(13), 1268–1269 (2020).
  • Bragazzi NL . Back to the ‘new normal’: researching and publishing in the time of the COVID-19 pandemic. J. Health Soc. Sci.5(4), 437–440 (2020).
  • Harrington L . COVID-19 technology-enabled living systematic reviews to enhance knowledge translation. AACN Adv. Crit. Care32(2), 133–136 (2021).
  • Djulbegovic B , GuyattGH. Progress in evidence-based medicine: a quarter century on. Lancet390(10092), 415–423 (2017).
  • Chirico F , Teixeirada Silva JA , MagnavitaN. “Questionable” peer review in the publishing pandemic during the time of COVID-19: implications for policy makers and stakeholders. Croatian Med. J.61(3), 300–301 (2020).
  • Chirico F , MagnavitaN. Predatory publishing and journals: how to address a profitable and ubiquitous business. Acta Neurochir.163, 2391–2392 (2022).
  • Chirico F , BramstedtKA. Research ethics committees: a forum where scientists, editors, and policymakers can cooperate during pandemics. Med. Sci. Law62(3), 230–232 (2022).
  • Kumar D , ChandraR , MathurM , SamdariyaS , KapoorN. Vaccine hesitancy: understanding better to address better. Isr. J. Health Policy Res.5, 2 (2016).
  • Li M , LuoY , WatsonRet al. Healthcare workers' (HCWs) attitudes and related factors towards COVID-19 vaccination: a rapid systematic review. Postgrad. Med. J. doi: 10.1136/postgradmedj-2021-140195 (2021) ( Online ahead of print).
  • Paterson P , MeuriceF , StanberryLR , GlismannS , RosenthalSL , LarsonHJ. Vaccine hesitancy and healthcare providers. Vaccine34(52), 6700–6706 (2016).
  • Cosgriff CV , EbnerDK , CeliLA. Data sharing in the era of COVID-19. Lancet Digital Health2(5), e224 (2020).
  • Rasmussen SA , JamiesonDJ. Public health decision making during Covid-19 – fulfilling the CDC pledge to the American people. New Engl. J. Med.383(10), 901–903 (2020).
  • Government of Ireland . Department of Health. Ethical framework for decision-making in a pandemic (2020). Available from: www.gov.ie/en/publication/dbf3fb-ethical-framework-for-decision-making-in-a-pandemic/ ( cited February 11, 2023).
  • UNESCO . Fighting COVID-19 through digital innovation and transformation. Available from: https://en.unesco.org/covid19/communicationinformationresponse/digitalinnovation ( cited February 11, 2023).
  • Morris L , SwoffordS. Vaccine safety. Prim. Care47(3), 431–441 (2020).
  • Ioannidis JPA . Coronavirus disease 2019: the harms of exaggerated information and non-evidence-based measures. Eur. J. Clin. Invest.50(4), e13222 (2020).
  • Lee TC , SenecalJ , HsuJM , McDonaldEG. Ongoing citations of a retracted study involving cardiovascular disease, drug therapy, and mortality in COVID-19. JAMA Intern. Med.181(11), 1535–1537 (2021).
  • Tripathy JP . Is publication ethics becoming a casualty of Covid-19?Indian J. Med. EthicsVI(1), 1–3 (2021).
  • Teixeira da Silva JA , Bornemann-CimentiH , TsigarisP. Optimizing peer review to minimize the risk of retracting COVID-19-related literature. Med. Health Care Philos.24(1), 21–26 (2021).
  • Chirico F , BragazziNL. Declaration of conflict of interest for reviewers in time of COVID-19 should be mandatory. Perspect. Clin. Res.12, 60–61 (2021).
  • Moorthy V , HenaoRestrepo AM , PreziosiMP , SwaminathanS. Data sharing for novel coronavirus (COVID-19). Bull. World Health Org.98(3), 150 (2020).
  • Garett R , YoungSD. Online misinformation and vaccine hesitancy. Transl. Behav. Med.11(12), 2194–2199 (2021).
  • Ebrahimi OV , JohnsonMS , EblingSet al. Risk, trust, and flawed assumptions: vaccine hesitancy during the COVID-19 pandemic. Front. Public Health9, 700213 (2021).
  • Pickering B , BiroT , AustinCCet al. Radical collaboration during a global health emergency: development of the RDA COVID-19 data sharing recommendations and guidelines [version 1]. Open Res. Europe1, 69 (2021).
  • EU . COVID-19 Data Portal. www.covid19dataportal.org/ ( cited February 11, 2023).
  • Harrison PW , LopezR , RahmanNet al. The COVID-19 Data Portal: accelerating SARS-CoV-2 and COVID-19 research through rapid open access data sharing. Nucleic Acids Res.49(W1), W619–W623 (2021).
  • Lin D , CrabtreeJ , DilloIet al. The TRUST principles for digital repositories. Sci. Data7(1), 144 (2020).
  • RDA COVID-19 WG: RDA COVID-19 Recommendations and Guidelines on Data Sharing. (Research Data Alliance working group (2020). Version 1.0, June 30). https://zenodo.org/record/3932953 ( cited February 11, 2023).
  • The Lancet Infectious Diseases . The COVID-19 infodemic. Lancet Infect. Dis.20(8), 875 (2020).
  • Rathore FA , FarooqF. Information overload and infodemic in the COVID-19 pandemic. J. Pak. Med. Assoc.70(Suppl. 3), S162–S165 (2020).
  • Eysenbach G . How to fight an infodemic: the four pillars of infodemic management. J. Med. Internet Res.22(6), e21820 (2020).
  • Wilson SL , WiysongeC. Social media and vaccine hesitancy. BMJ Global Health5(10), e004206 (2020).
  • Ahmed W , Vidal-AlaballJ , DowningJ , LópezSeguí F. COVID-19 and the 5G conspiracy theory: social network analysis of twitter data. J. Med. Internet Res.22(5), e19458 (2020).
  • Chirico F . The new Italian mandatory vaccine law as a health policy instrument against the anti-vaccination movement. Ann. Ig.30(3), 251–256 (2018).
  • Schernhammer E , WeitzerJ , LaubichlerMDet al. Correlates of COVID-19 vaccine hesitancy in Austria: trust and the government. J. Public Health44(1), e106–e116 (2022).
  • Alvarez-Risco A , MejiaCR , Delgado-ZegarraJet al. The Peru approach against the COVID-19 infodemic: insights and strategies. Amer. J. Trop. Med. Hyg.103(2), 583–586 (2020).
  • Hernandez RG , HagenL , WalkerK , O'LearyH , LengacherC. The COVID-19 vaccine social media infodemic: healthcare providers' missed dose in addressing misinformation and vaccine hesitancy. Human Vaccine Immunother.17(9), 2962–2964 (2021).
  • Gisondi MA , BarberR , FaustJSet al. A deadly infodemic: social media and the power of COVID-19 misinformation. J. Med. Internet Res.24(2), e35552 (2022).
  • NHS . NHS Takes Action against Coronavirus Fake News Online (2020). www.england.nhs.uk/2020/03/nhs-takes-action-against-coronavirus-fake-news-online/ ( cited February 11, 2023).
  • Kaliyar RK , GoswamiA , NarangP , SinhaS. FNDNet – a deep convolutional neural network for fake news detection. Cogn. Syst. Res.61, 32–44 (2020).
  • Dib F , MayaudP , ChauvinP , LaunayO. Online mis/disinformation and vaccine hesitancy in the era of COVID-19: why we need an eHealth literacy revolution. Human Vaccine Immunother.18(1), 1–3 (2022).
  • Cardenas NC . ‘Europe and United States vaccine hesitancy’: leveraging strategic policy for ‘infodemic’ on COVID-19 vaccines. J. Public Health44(2), e315–e316 (2022).
  • Dror AA , EisenbachN , TaiberSet al. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur. J. Epidemiol.35(8), 775–779 (2020).
  • Vivion M , GauvinL. Integrating infoveillance, infodemiology, and consequential intervention research in our public health systems to better protect and promote the health of Canadians: ideas and perspectives. Can. J. Public Health113(1), 147–154 (2022).
  • Mheidly N , FaresJ. Leveraging media and health communication strategies to overcome the COVID-19 infodemic. J. Public Health Policy41(4), 410–420 (2020).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.